We found that high SIRT1 expression at stage (I + II) in 78 male patients with colorectal cancer was associated with poor prognosis for relapse-free survival (RFS) [hazard ratio (HR): 2.11, log-rank p = 0.025] (Figure 5A). This evidence concerns the gene SIRT1 and colorectal cancer.